QScreen AI Announces Strategic Financing to Advance Commercialization Initiatives Across North America

Executive Summary

• QScreen AI Inc. announced a non‑brokered private placement of up to 10 million units at C$0.05 per unit, targeting gross proceeds of up to C$500,000.
• Each unit consists of one common share and half of a warrant allowing purchase of an additional half share at C$0.15 for 36 months; warrants may be accelerated if the CSE price reaches C$0.30 for ten consecutive trading days.
• Proceeds will fund pilot discussions, operational integration planning with select partners, and working‑capital needs to scale commercialization across healthcare, industrial, and technology sectors.

Key Details

• Offering Size: Up to 10,000,000 units (each = 1 common share + ½ warrant).
• Price per Unit: C$0.05 → maximum gross proceeds of C$500,000.
• Warrant Terms: Right to purchase one half common share at C$0.15; exercisable for 36 months after closing.
• Accelerated Expiry Clause: If, ≥ 4 months + 1 day post‑closing, the volume‑weighted average price of QScreen AI’s common shares on the CSE is ≥ C$0.30 for any 10 consecutive trading days, the company may accelerate warrant expiry to 30 days after written notice.
• Use of Proceeds:
• Advance structured pilot discussions and operational integration planning with select organizations (building on recent Canadian Trade Mission engagements in Mexico).
• Support working‑capital requirements associated with scaling commercialization efforts across enterprise‑scale healthcare, industrial, and technology sectors.
• Investor Interest: Preliminary indications of interest received from select investors, indicating strong market demand for the financing.

Notable Quotes

(No direct quotes were provided in the release.)